Johannes Nagel

Johannes Nagel has a diverse work experience in the field of radiochemistry and research. Johannes is currently working as a Principal Scientist Radiochemistry at Y-mAbs Therapeutics, Inc. since January 2022. Prior to this role, they served as a CMC Project Manager Radiochemistry at the same company starting from May 2020.

Before joining Y-mAbs Therapeutics, Inc., Johannes worked at ITM Isotope Technologies Munich SE from December 2017 to May 2020 as a Radiochemist (R&D), where they were involved in the production and purification of n.c.a.

From November 2012 to October 2017, Johannes was a Wissenschaftlicher Mitarbeiter mit akademischem Abschluss at Johannes Gutenberg-Universität Mainz.

In addition, they gained research experience as a Research Student at Arizona State University from August 2010 to February 2011.

Overall, Johannes Nagel's work experience spans roles in radiochemistry, project management, and research, showcasing their expertise in these areas.

Johannes Nagel has a diverse educational background. Johannes first attended Johannes Gutenberg University Mainz from 2007 to 2012, where they obtained a Diplom-Chemiker degree in Chemistry. During this time, they also spent a year studying Bioanorganic Chemistry at Arizona State University from 2010 to 2011.

After completing their undergraduate studies, Johannes went on to pursue a Ph.D. at Johannes Gutenberg University Mainz from 2013 to 2017, focusing on Chemistry. Following their doctoral degree, they obtained the certification of Diplom-Chemiker from Johannes Gutenberg-Universität Mainz in August 2013.

In 2019, Johannes enrolled in SRH Hochschule Heidelberg, where they completed a GMP-Expert program in Pharmazeutik und Arzneimitteldesign, specializing in pharmaceuticals and drug design. Johannes'senrollment at SRH Hochschule Heidelberg lasted until 2020.

In addition to their formal education, Johannes has also obtained several certifications. In March 2021, they completed ECA - Live Online Training GMP and Quality Requirements for Radiopharmaceuticals at CONCEPT HEIDELBERG GmbH. Furthermore, in October 2018, they acquired the Fachkunde nach Strahlenschutzverordnung StrlSchV (Module GH, OG, OH, FA) certification; however, the institution granting this certification is unknown.

Overall, Johannes Nagel's educational journey showcases a strong commitment to Chemistry and pharmaceutical-related studies, with a focus on both theoretical and practical aspects in various academic institutions.